Xing Zeng

Title: Innovations of Inventor Xing Zeng

Introduction

Xing Zeng is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of cell cycle research, holding 2 patents that focus on innovative methods for treating cell cycle disorders.

Latest Patents

Zeng's latest patents include "Cell permeable inhibitors of anaphase promoting complex" and "Inhibitors of anaphase promoting complex activity." The first patent provides compositions and methods for treating cell cycle disorders, including proTAME, a prodrug analog of TAME, and apcin, which work synergistically to inhibit the activity of the anaphase promoting complex (APC). The second patent offers an anti-proliferative composition that comprises a non-peptide analog of the C-terminal isoleucine-arginine (IR) tail motif of an APC activator. This invention also outlines methods for inhibiting the ubiquitination activity of the APC through the administration of these compositions.

Career Highlights

Xing Zeng is affiliated with Harvard College, where he conducts his research and develops his innovative solutions. His work has garnered attention for its potential applications in medical treatments and therapies.

Collaborations

Zeng collaborates with esteemed colleagues, including Randall W King and Katharine L Sackton, who contribute to his research endeavors and enhance the impact of his inventions.

Conclusion

Xing Zeng's contributions to the field of cell cycle research through his patents demonstrate his commitment to innovation and the advancement of medical science. His work continues to pave the way for new therapeutic approaches to cell cycle disorders.